PLA2G6 anticorps (Internal Region)

N° du produit ABIN7186925

Détail du produit anti-PLA2G6 anticorps

Antigène: PLA2G6 (Phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6))

Épitope: Internal Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2G6 est non-conjugé

Application: Western Blotting (WB), ELISA

Réactivité croisée: Humain, Souris, Rat

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogène: Synthesized peptide derived from the Internal region of Human Group VI iPLA2.

Isotype: IgG

Information d'application

Indications d'application: WB:1:500-1:2000, ELISA:1:5000,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur PLA2G6

Antigène: PLA2G6 (Phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6))

Autre désignation: PLA2G6 (PLA2G6 Produits)

Synonymes: anticorps zgc:77476, anticorps wu:fc06g09, anticorps PNPLA9, anticorps MGC83523, anticorps PLA2G6, anticorps BB112799, anticorps iPLA(2)beta, anticorps iPLA2, anticorps iPLA2beta, anticorps CaI-PLA2, anticorps GVI, anticorps INAD1, anticorps IPLA2-VIA, anticorps NBIA2, anticorps NBIA2A, anticorps NBIA2B, anticorps PARK14, anticorps PLA2, anticorps iPla2, anticorps phospholipase A2, group VI (cytosolic, calcium-independent), anticorps phospholipase A2 group VI, anticorps phospholipase A2 group VI S homeolog, anticorps 85/88 kDa calcium-independent phospholipase A2, anticorps phospholipase A2, group VI, anticorps pla2g6, anticorps PLA2G6, anticorps pla2g6.S, anticorps LOC100445065, anticorps Pla2g6

Sujet: 85 kDa calcium independent phospholipase A2 antibody, 85/88 kDa calcium-independent phospholipase A2 antibody, BB112799 antibody, CaI PLA2 antibody, CaI-PLA2 antibody, CaIPLA2 antibody, Calcium independent phospholipase A2 antibody, CTA-228A.2 antibody, Cytosolic calcium independent phospholipase A2 antibody, EC 3.1.1.4 antibody, Group VI phospholipase A2 antibody, Group VI, A antibody, GVI antibody, GVI PLA2 antibody, INAD1 antibody, Intracellular membrane associated calcium independent phospholipase A2 beta antibody, Intracellular membrane-associated calcium-independent phospholipase A2 beta antibody, iPLA(2)beta antibody, iPLA2 beta antibody, iPLA2-beta antibody, IPLA2-VIA antibody, iPLA2beta antibody, NBIA2 antibody, NBIA2A antibody, NBIA2B antibody, Neurodegeneration with brain iron accumulation 2 antibody, OTTHUMP00000199457 antibody, PARK14 antibody, Patatin like phospholipase domain containing 9 antibody, Patatin like phospholipase domain containing protein 9 antibody, Patatin-like phospholipase domain-containing protein 9 antibody, Phospholipase A2 calcium independent antibody, Phospholipase A2 calcium independent group VI A antibody, Phospholipase A2 group VI antibody, Phospholipase A2 group VI cytosolic calcium independent antibody, Phospholipase A2, group VI (cytosolic, calcium independent) antibody, PLA2 antibody, PLA2G6 antibody, PLPL9_HUMAN antibody, PNPLA9 antibody

UniProt: O60733

Pathways: Positive Regulation of Peptide Hormone Secretion